Yahoo Finance

Worldwide Endocrine Test Industry to 2026 - by Type, Application, End-user and Country

Dublin, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The "Endocrine Test Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026" ...
Yahoo Finance

Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Morningstar

Hologic to Present New Data at ASCO 2026 Demonstrating the Clinical Impact of the Breast Cancer Index® Test on Extended Endocrine Therapy Decisions

Hologic, Inc. and its subsidiary, Biotheranostics, Inc., today announced new data demonstrating how the Breast Cancer Index® (BCI™) Test results influence extended endocrine therapy decisions for ...
The American Journal of Managed Care

Test Predicts Benefit of Extended Endocrine Therapy in Breast Cancer Patients

bioTheranostics, Inc's Breast Cancer Index, a genomic test quantifying the risk of breast cancer recurrence and predicting which patients will likely benefit from extended endocrine therapy, will be ...
Nasdaq

Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions

Hologic’s HOLX acquisition of Biotheranostics in 2021 accelerated its entry into a large, fast-growing oncology adjacency. The business also carries higher margins than the company’s legacy service ...